CureVac announces 48 percent efficacy in COVID-19 vaccine
chinadaily.com.cn | Updated: 2021-07-02 03:37
German biotech firm CureVac has announced its COVID-19 vaccine has 48 percent efficacy, based on final trial results.
Editor's Pick
chinadaily.com.cn | Updated: 2021-07-02 03:37
German biotech firm CureVac has announced its COVID-19 vaccine has 48 percent efficacy, based on final trial results.